Loading Results

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Find Clinical Trials & Studies

Visit the Research & Education Institute

BA3071 + NIVOLUMAB in ADVANCED SOLID TUMORS

Back to Search Results

I'm Interested!

Please call
1-800-641-2422

A Phase 1/2 Study of BA3071 in Combination with Nivolumab in Patients with Advanced Solid Tumors

Sex at Birth: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Cancer - Solid Tumor

Study Purpose

The objective of this study is to assess safety and efficacy of BA3071 in solid tumors

Principal Investigator
Ankit Mangla MD

Department/Division
Cancer (Any Solid Tumor)

Locations

UH Seidman Cancer Center
11100 Euclid Avenue
Cleveland OH, 44106

UH IRB: STUDY20220942
StudyID: BATLA1Y22
ClinicalTrials.gov: NCT05180799

I'm Interested!

Please call
1-800-641-2422

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422